The evolving host: how the environment, patient and new treatments are shaping the IFI landscape
A series of online interactive sessions
Session 1: Friday, 2 October; 15:00–17:25
Session 2: Saturday, 3 October; 10:00–12:25
Session 3: Friday, 9 October; 15:00–17:05
Due to the COVID-19 pandemic, GAIN 2020 will be brought to you as an online multi-session event, where you will have the option to join one, two or all three of the sessions. The programme is designed to advance the management of invasive fungal disease by sharing knowledge and best practice on how to deal with the changing landscape of fungal infection in response to external factors that are shaping patient risk and susceptibility.
Through a series of three virtual sessions (each session length is between 2h05–2h25) we will explore how environmental factors, treatment practices, and lifestyle choices are shaping fungal disease. Knowledge will be shared through plenary presentations and case reports, with interactive Q&A sessions across the day. CPD points will be awarded in accordance with the number of sessions attended.
Session 1 will address how COVID-19 has, and will have, a major impact across many medical disciplines including the treatment of invasive fungal disease. Pertinent to COVID-19 we will discuss respiratory fungal infection and how viruses are shaping the risk of invasive fungal infections (IFIs).
Session 2 will consider the impacts of prophylaxis and the emergence of breakthrough IFIs, alongside discussions on new advances in mycology in the latest published literature.
Session 3 will explore through a series of case studies how more unusual situations related to the natural environment and personal circumstances can lead to IFIs.
GAIN 2020 is open to healthcare professionals that are associated with an institution based in the UK and Ireland only.